{"id":"https://openalex.org/W4286294393","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e13643","title":"Clinicians\u2019 perspective on use of immune checkpoint inhibitors and related biomarkers for solid tumors.","display_name":"Clinicians\u2019 perspective on use of immune checkpoint inhibitors and related biomarkers for solid tumors.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4286294393","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e13643"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.e13643","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e13643","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e13643","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053839100","display_name":"Kaitlynn Moser","orcid":"https://orcid.org/0000-0001-9027-802X","observed_orcids":["https://orcid.org/0000-0001-9027-802X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kaitlynn Moser","raw_affiliation_strings":["Venn Biosciences Corporation, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Venn Biosciences Corporation, Redwood City, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060041987","display_name":"Klaus Lindpaintner","orcid":"https://orcid.org/0000-0002-6923-4900","observed_orcids":["https://orcid.org/0000-0002-6923-4900"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Klaus Lindpaintner","raw_affiliation_strings":["InterVenn, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InterVenn, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027334050","display_name":"Michelle Soto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle Soto","raw_affiliation_strings":["Olsen Research Group, Yardley, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Olsen Research Group, Yardley, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085689503","display_name":"Daniela Geba","orcid":"https://orcid.org/0000-0003-1287-3530","observed_orcids":["https://orcid.org/0000-0003-1287-3530"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniela Geba","raw_affiliation_strings":["Ascenian Consulting and Market Research, Webster, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ascenian Consulting and Market Research, Webster, NY;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058678580","display_name":"Paul D. Allen","orcid":"https://orcid.org/0000-0002-4924-4730","observed_orcids":["https://orcid.org/0000-0002-4924-4730"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Allen","raw_affiliation_strings":["Olsen Research Group, Yardley, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Olsen Research Group, Yardley, PA;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"e13643","last_page":"e13643"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":1.0},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8320000171661377},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.9739999771118164},{"id":"https://openalex.org/keywords/oncologist-perspectives","display_name":"oncologists' perspectives","score":0.7770000100135803},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.8519999980926514},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.9959999918937683},{"id":"https://openalex.org/keywords/microsatellite-instability","display_name":"microsatellite instability","score":1.0},{"id":"https://openalex.org/keywords/driver-mutations","display_name":"driver mutations","score":0.953000009059906},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8740000128746033},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.8289999961853027},{"id":"https://openalex.org/keywords/unmet-needs","display_name":"unmet needs","score":0.6669999957084656},{"id":"https://openalex.org/keywords/biomarker-reliability","display_name":"biomarker reliability","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9133549928665161},{"id":"https://openalex.org/C2779767149","wikidata":"https://www.wikidata.org/wiki/Q488212","display_name":"Microsatellite instability","level":5,"score":0.7715660929679871},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5347411036491394},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5324844717979431},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5174082517623901},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5036248564720154},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4847354590892792},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3500787019729614},{"id":"https://openalex.org/C61320498","wikidata":"https://www.wikidata.org/wiki/Q265193","display_name":"Microsatellite","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.e13643","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e13643","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e13643","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4386812704","https://openalex.org/W3128096706","https://openalex.org/W4290790590","https://openalex.org/W4399578568","https://openalex.org/W4402749216","https://openalex.org/W4375955030","https://openalex.org/W4399856128","https://openalex.org/W3016652423","https://openalex.org/W2947849947","https://openalex.org/W4404666173"],"abstract_inverted_index":{"e13643":[0],"Background:":[1],"Immune":[2],"checkpoint":[3],"inhibitors":[4],"(ICIs)":[5],"are":[6,25],"a":[7,78,177,251],"valuable":[8],"treatment":[9,47,139,255],"option":[10],"for":[11,46,208,225,257],"patients":[12,19,103,258],"with":[13,104,124,150,259],"malignant":[14,49],"tumors,":[15,261],"but":[16],"only":[17,98],"selected":[18],"respond":[20],"to":[21,35,52,57,108,114,137,214,231],"ICIs.":[22],"Available":[23],"biomarkers":[24,45,136,169,207,248],"of":[26,42,48,66,83,87,101,119,133,135,141,144,152,157,164,188,211,218],"limited":[27],"use":[28,41,82,151,232],"in":[29,91,126,221],"guiding":[30],"ICI":[31,226],"therapy.":[32],"We":[33,61],"sought":[34],"examine":[36],"clinicians\u2019":[37],"perspective":[38],"on":[39,254],"the":[40,102,111,127,131,147,223],"ICIs":[43,115],"and":[44,51,69,85,160,183,197,267],"tumors":[50,106,120],"identify":[53],"unmet":[54],"needs":[55],"related":[56],"their":[58,215],"use.":[59],"Methods:":[60],"conducted":[62],"in-depth":[63],"telephone":[64],"interviews":[65],"eight":[67],"oncologists,":[68],"100":[70],"oncologists":[71],"completed":[72],"online":[73],"surveys.":[74],"Results:":[75],"Oncologists":[76,202],"have":[77,250],"positive":[79],"attitude":[80],"toward":[81],"ICIs,":[84,153],"98%":[86],"them":[88,90],"prescribe":[89],"all":[92],"approved":[93],"indications.":[94],"Clinicians":[95,241],"report":[96],"that":[97,204,243],"about":[99],"half":[100],"solid":[105,260],"responded":[107],"treatment,":[109],"overestimating":[110],"response":[112],"rate":[113],"across":[116],"most":[117,170],"types":[118],"they":[121,205],"treat,":[122],"compared":[123],"data":[125],"literature.":[128],"They":[129],"ranked":[130],"lack":[132,156],"reliability":[134],"guide":[138],"(rating":[140],"4.4":[142],"out":[143],"7)":[145],"as":[146,235],"top":[148],"challenge":[149],"followed":[154],"by":[155,173],"overall":[158],"efficacy":[159],"toxicity":[161],"or":[162,237],"occurrence":[163],"immune-related":[165],"adverse":[166],"events.":[167],"The":[168],"often":[171],"used":[172],"survey":[174],"participants":[175],"were:":[176],"comprehensive":[178],"panel":[179],"including":[180],"driver":[181],"mutations":[182],"tumor":[184],"mutational":[185],"burden":[186],"(69%":[187],"respondents),":[189],"programmed":[190],"cell":[191],"death":[192],"ligand-1":[193],"(PD-L1)":[194],"expression":[195],"(62%),":[196],"microsatellite":[198],"instability":[199],"(MSI)":[200],"(56%).":[201],"indicated":[203],"ordered":[206],"each":[209,219],"type":[210],"cancer":[212],"according":[213],"perceived":[216,234],"usefulness":[217],"biomarker":[220],"predicting":[222],"outcomes":[224],"therapy,":[227],"being":[228],"more":[229,244],"likely":[230],"those":[233],"useful":[236],"very":[238],"useful.":[239],"Conclusions:":[240],"indicate":[242],"reliable":[245],"therapy-response":[246],"prediction":[247],"would":[249],"great":[252],"impact":[253],"decisions":[256],"reducing":[262],"unnecessary":[263],"treatments,":[264],"side":[265],"effects,":[266],"health":[268],"care":[269],"expenditures.":[270]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2022-07-21T00:00:00"}